Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AMD device firm Oraya gets $42mm in Series C round

Executive Summary

Oraya Therapeutics (devices for neovascular ophthalmic diseases) grossed $42mm through its Series C financing, which was led by first-time investors Scale Venture Partners and Domain Associates and included existing backers Essex Woodlands Health Ventures and Synergy Life Partners. Members of Scale and Domain joined the company's board.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies